GO:0160064 multi-pass translocon complex: Components, Assembly and Research Methods

The multi-pass translocon complex (GO:0160064) is a recently defined endoplasmic reticulum (ER) membrane protein complex that specifically mediates the insertion of multi-pass transmembrane proteins into the ER membrane. Unlike the canonical Sec61 translocon, which handles a broad range of secretory and membrane proteins, this complex appears dedicated to the challenging task of inserting proteins with multiple transmembrane domains. Its discovery reshaped the view of ER protein biogenesis by showing that multi-pass membrane proteins require a distinct insertion machinery. The complex comprises three subcomplexes: GEL (RAB5IF/OPTI and TMCO1), BOS (NCLN/Nicalin, NOMO, and TMEM147), and PAT (WDR83OS/Asterix and CCDC47). Understanding its structure, assembly, and substrate specificity is essential for researchers studying membrane protein folding, ER homeostasis, and related diseases. Because multi-pass membrane proteins include receptors, channels, and transporters, defects in this complex can have broad physiological consequences. This article summarizes the current knowledge of GO:0160064, its components, mechanisms, and experimental approaches for its study.

The multi-pass translocon complex is a protein complex in the endoplasmic reticulum membrane that mediates the insertion of multi-pass transmembrane proteins into the ER membrane. Substrates enter through the lateral gate of the Sec61 translocon and are then processed by this complex. It is composed of three subcomplexes: the GEL subcomplex (RAB5IF/OPTI and TMCO1), the BOS subcomplex (NCLN/Nicalin, NOMO, and TMEM147), and the PAT subcomplex (WDR83OS/Asterix and CCDC47). This definition is based on the QuickGO entry for GO:0160064.

The multi-pass translocon complex is important because it fills a critical gap in ER protein biogenesis: the dedicated insertion of multi-pass transmembrane proteins, which are essential for cell signaling, transport, and adhesion. Its discovery revealed that Sec61 alone is insufficient for many multi-pass proteins, and that a specialized machinery exists to ensure their correct topology and function. Dysregulation of this complex can lead to protein misfolding, ER stress, and disease, as evidenced by mutations in TMCO1 and TMEM147 that cause human disorders. Studying GO:0160064 therefore provides insights into fundamental cell biology and offers potential therapeutic targets for diseases linked to membrane protein biogenesis.

The following genes encode the core subunits of the multi-pass translocon complex and are central to its function and regulation.

The multi-pass translocon complex is regulated at multiple levels, including transcriptional control of its subunits and post-translational modifications. Its activity may be coupled to ER stress responses, as loss of subunits induces ER stress and upregulates chaperones. The PAT subcomplex component CCDC47 is involved in ER calcium homeostasis, suggesting that calcium signaling can influence complex function. Additionally, the complex may be regulated by the availability of substrates and by interactions with Sec61 and other ER membrane proteins. Further studies are needed to fully elucidate its regulatory mechanisms.

Mutations in TMCO1 and TMEM147, components of the multi-pass translocon complex, have been linked to craniofacial dysmorphism and skeletal abnormalities. These findings suggest that defective multi-pass membrane protein biogenesis contributes to developmental disorders. The complex is therefore a potential target for understanding and treating such conditions.

Dysfunction of the multi-pass translocon complex can lead to ER stress, which is implicated in neurodegenerative diseases. Impaired insertion of multi-pass membrane proteins may disrupt neuronal signaling and survival. Further research is needed to establish direct links to specific neurodegenerative conditions.

Altered expression of multi-pass translocon complex subunits has been observed in some cancers, potentially affecting membrane protein profiles that drive proliferation. Targeting the complex could offer therapeutic opportunities, but more studies are required.

Affinity purification coupled with mass spectrometry (AP-MS) can identify subunits and interactors of the multi-pass translocon complex. Proximity labeling using knock-in tags enables mapping of the complex environment in living cells. These methods help define the composition and dynamics of the complex.

Cryo-electron microscopy (cryo-EM) and X-ray crystallography can resolve the architecture of the complex and its subcomplexes. Structural studies of the related ER membrane complex provide a framework for understanding multi-pass translocon function. These approaches reveal how substrates are inserted and how subunits interact.

Knockout cell lines combined with reporter assays can measure defects in multi-pass membrane protein biogenesis. RNA-seq and Ribo-seq can assess changes in gene expression and translation upon complex disruption. These functional assays link the complex to cellular phenotypes.

Fluorescence microscopy of tagged subunits can visualize the localization and dynamics of the complex in the ER. Super-resolution imaging may reveal subcomplex organization. Live-cell imaging can track substrate insertion in real time.

Researchers studying multi-pass translocon complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, substrate insertion, or disease. EDITGENE provides comprehensive CRISPR services to accelerate this research.

The multi-pass translocon complex (GO:0160064) represents a specialized ER machinery for the biogenesis of multi-pass transmembrane proteins, with critical roles in cellular function and disease. Its three subcomplexes coordinate substrate recognition, membrane insertion, and quality control, offering rich opportunities for mechanistic and therapeutic research. Continued studies using CRISPR models and advanced structural techniques will further illuminate its biology and links to human disorders.